The link between acetaminophen and elevated blood pressure is underappreciated. While less common, high blood pressure has ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Want a say in the news? Email Claudia at todayinpa@pennlive.com to have your thoughts on the stories covered here or on ...

The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...